-
mutation
responsible for most resistance in an organism
occurs constantly in nature, unrelated to antibiotics
-
transduction
transfer of drug resistance gene from one cell to another via a phage
-
transformation
uptake of drug resistance plasmids (DNA), present in the immediate environment
-
conjugation
transfer of resistance genes via direct contact through a sex pilus or bridge
involves resistance factor (RF) and resistance transfer factor (RTF)
a single plasmid can confer multiple drug resistance
-
MIC vs. MBC
minimal inhibatory concentration shows no growth in 24 hours
minimal bacteriocidal concentration (99.9% killed)
MIC usually sufficient in choosing dose, unless using a drug with low threapeutic index on a severe infection
-
importance of the location of infection when choosing a drug
must always have the MIC at the site of infection, since not all drugs penetrate equally into all parts of the body
-
importance of renal function in choosing an antibiotic
most antimicrobials are excreted by the kidneys
impaired renal function = sustained blood levels
-
route of administration in choosing abx
determined by properties of the drug and severity of infection
some drugs are not well absorbed after oral dosing, like vancomycin
-
neutropenic patients and abx
pt w/ immune disorder not usually given bacteriostatic drug
-
drug allergies when choosing abx
all antimicrobial agents have the potential to cause a reaction
most common offenders are penicillins
THERE IS NO WAY TO ABSOLUTELY PREDICT WHETHER A PT WILL HAVE A REACTION
skin tests are not always diagnostic
-
indications to treat with combined antimicrobial agents
- 1. Tx of mixed infections
- 2. Tx of severe infections when etiology is not known (CYA principle)
- 3. Enhancement of antimicrobial activity in treating a known infection (synergy)
- - penicillin and streptomycin in treating enterococcal endocarditits
- 4. Prevention of emergence of resistant organisms (often in TB Tx)
-
disadvantages of combined antimicrobial therapy
- 1. Drug antagonism (bacteriostatic drug used with a bacteriocidal drug)
- 2. Unnecessary patient exposure (toxic effects can also be synergistic)
-
most extensive use of antimicrobial prophylaxis
prevention of wound infection during surgery
-
misuses of antimicrobial agents
- 1. Treatment of untreatable infections (viral, etc)
- 2. Therapy of a fever of undetermined orgins
- 3. Improper dose (can be from lack of pt compliance)
- 4. Reliance on chemotherapy with omission of surgical drainage
- 5. Lack of adequate bacteriological information (ID of MO, sensitivity, etc)
-
def. of suprainfections
emergence of resistant organisms, often in the GI tract, after reduction by antimicrobial agents of the more susceptable organisms
often from Clostridium difficile
CHANCES OF A SUPRAINFECTION IS DIRECTLY RELATED TO THE WIDTH OF ANTIMICROBIAL SPECTRUM OF THE DRUG
-
common use of sulfonamides
treatment of urinary tract infections due to susceptable bacteria
-
sulfonamides are all structural analogs of ....
PABA, which is needed to make folic acid
-
mechanism of action of sulfanomides
inability to make folic acid
without folic acid, the cell has less tetrahydrofolate available
therefore, cell is unable to convert dUMP to TMP
therefore, inhibition of folic acid synthesis prevents bacteria from replicating DNA
-
action of sulfanomides
BACTERIOSTATIC
therefore, sulfanomides have little or no effect without a competant immune system
can't be used with bacteriocidal drugs, b/c will reduce their effectiveness
-
microbial resistance to sulfanomides
microbes with greatly enhanced levels of PABA and folic acid
the increased levels of these substrates bypass the metabolic block caused by the drug
-
toxicity of sulfanomides
- 1. agranulocytosis (rare, usually can be reversed)
- 2. thrombocytopenia (mild)
- 3. aplastic anemia (very rare, can be fatal)
- 4. acute hemolytic anemia (assoc. w/ lack of erythrocyte glucose-6-phosphate dehydrogenase activity; most commonly seen in blacks)
-
most severe hypersensitivity to sulfonamides
Stevens-Johnson syndrome
-
major use of sulfonamide today is with...
trimethoprim
-
how trimethoprim works
inhibits dihydrofolate reductase
the mammalian DHFR is only inhibited at concentrations over 10,000x higher than the bacterial enzymes, therefore safe in humans
-
cause of trimethoprim resistance
mutant DHFR enzyme which will no longer bind the drug
-
therapeutic uses of sulfonamide plus trimethoprim
uncomplicated lower urinary tract infections
GI infections
pneumocystis carnii infections (common in AIDS patients)
prophylaxis in neutropenic patients (organ transplant patients)
-
common action of both sulfonamides and trimethoprim
prevent the production of tetrahydrofolate-C1 and threfore inhibits synthesis of DNA
both are bacteriostatic
-
major mechanism of resistance for sulfanomides and trimethoprim
sulfa: overproduction of PABA
TMP: mutant DHFR enzyme will not bind the drug
-
how beta lactam drugs work
inhibit cell-wall synthesis in bacteria
-
enzyme inhibited by penicillin
transpeptidase (inserts bridge in the last step in formation of the cell wall)
-
acid stable penicillins
penicillin V (same action, but better absorbed in GI tract)
-
penicillinase resistant penicillins
methicillin (these drugs should be used only when it is known that the infecting bacteria produces penicillinase)
-
broader spectrum penicillins
ampicillin, amoxicillin
active against gram negative bacteria, but are destroyed by beta lactamases
-
penicillin metabolism
all penicillins are excreted almost unchanged
through glomerular filtration
the exception is cloxacillin (metabolized in liver)
-
penicillin hypersensitivity
often mild, but can include anaphylaxis
-
MRSA
major cause of hospital-acquired infections
do not produce penicillinases
resistant to other beta-lactam antibiotics as well as other antimicrobial agents of diverse structures and modes of action
can be acquired by mecA gene
-
mode of action of cephalosporins
identical to penicillins
very similar side effects
there is a high cross-over of penicillin allergic patients that are also allergic to cephalosporins
-
1st generattion cephalosporins
- 1. cephalothin (parenteral only, easily broken down by staphylococcal beta lactamase)
- 2. cefazolin (more susceptable to beta lactamase)
-
2nd generation cephalosporins
more active against gram negative than first generation
- 1. cefamandole (can't drink alcohol on this drug due to "disulfuram reaction")
- 2. cefuroxime (like the first, but longer acting)
-
3rd generation cephalosporins
ceftriaxone (long half life, very effective in treating gonorrhea)
-
therapeutic uses of cephalosporins
prophylaxis during and after surgery
3rd generation groups are DOC for meningitis caused by gram negative bacteria
ceftriaxone used to treat gonorrhea, unless strain is tested to be sensitive to penicillin
sometimes used as penicillin alternative in patients that can't take PCN (although some are allergic to both)
-
adverse rxn to cephalosporins
hypersensitivity
"disulfuram" reaction with alcohol (cefamandole, cefoperazone)
-
beta-lactamase inhibitors
clavulanic acid
has no bacteriostatic or cidal features
combined with amoxicillin to make Augmentin
-
bacitracin
inhibitors of cell-wall synthesis by inhibiting a phosphatase enzyme
very few side effects
-
fosfomycin
inhibits MurA, which catalyzes the first step in making peptidoglycan
bacteriocidal
can be used as a single dose Tx for urinary tract infections
safe to use in pregnancy
-
vancomycin
binds to D-ALA-D-ALA, so cell wall can't polymerize
"red man syndrome" if given rapidly IV (anaphylaxis, fever, shock-like state)
very expensive
resistance is a growing problem
-
major uses of vancomycin
DOC for MRSA
DOC for antibiotic associated colitis (AAC)
-
enzyme involved in linking reaction of protein synthesis
peptidyl transferase
-
major uses of aminoglycosides
treatment of infections caused by aerobic gram negative bacteria
often given with beta lactam drug, but not in the same solution
-
mechanism of action of aminoglycosides
- 1. streptomycin (interacts with the 30s subunit of the ribosome)
- - blocks protein synthesis at the level of initiation
ALL aminoglycosides are bacteriocidal
-
aminoglycoside resistance
most important mechanism is "resistance caused by aminoglycoside modifying enzymes" which inactivate the drug
the genes for these enzymes are carried on plasmids which are conjugally transmitted
AMIKACIN AND NETILMICIN ARE UNIQUELY RESISTANT TO THE DRUG MODIFYING ENZYMES
-
aminoglycoside side effects
- damage to 8th cranial nerve (irreversible)
- - loss of sensory cells in vestibulocochlear organs
-
therapeutic index of aminoglycosides
very narrow
|
|